Dr. David I Hantman I, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 333 E Nutwood St Ste C, Inglewood, CA 90301 Phone: 310-912-6100 Fax: 310-912-6105 |
Eugene Christian, EUGENE CHRISTIAN Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 101 N La Brea Ave, 306, Inglewood, CA 90301 Phone: 310-671-3328 |
Steven A Lerner, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 501 E Hardy St, Suite 430, Inglewood, CA 90301 Phone: 310-671-7010 Fax: 310-680-6855 |
Stephen Ac Parnell, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 501 E Hardy St, Suite 430, Inglewood, CA 90301 Phone: 310-671-7010 Fax: 310-680-6855 |
Mark Lott, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 501 E Hardy St, Suite 430, Inglewood, CA 90301 Phone: 310-671-7010 Fax: 310-680-6855 |
News Archive
Ipsen today announced its decision to assess the alternative development of Irosustat (BN 83495) in combination with other hormonal therapies. This decision is based on the futility analysis from the proof-of-concept trial phase II clinical study carried out in Europe in monotherapy in endometrial cancer, and on the phase I/II clinical study results obtained in metastatic prostate and breast cancers.
Nearly every state is considering or already making cuts to its Medicaid program as the recession swells rolls for the state-run health insurance program for the poor, The New York Times reports. Because of requirements for getting stimulus money to support programs, the states are not allowed to curb enrollment, and are instead cutting optional benefits and reimbursement rates. Lower rates could drive more physicians and other providers away from the program, which already pays very low fees.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
When a cell divides into two daughter cells, it must replicate its DNA according to a very specific scenario. In the presence of some disruptive elements, however, cancer cells are unable to perform this operation optimally; replication then takes place more slowly and less efficiently.
› Verified 5 days ago